ArticleChemical senses2025
The peri-ovulatory time period in humans is associated with increased taste sensitivity to glucose but not calorie-free sweeteners.
Article in Chemical senses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Recent research has shown that KATP channels in mouse taste bud cells enhance glucose taste signaling by depolarizing the cell when ATP is present. Relatedly, estradiol has been shown to enhance glucose sensing in human pancreatic β cells via closure of KATP channels. Since taste tissue has estradiol receptors, we linked these 2 observations and tested whether elevated estradiol may also enhance taste sensitivity and liking for glucose in humans. We hypothesized that around the time of ovulation, when estrogen peaks during the menstrual cycle in female participants, oral taste detection thresholds for glucose (metabolizable monosaccharide) would decrease but would not for sucralose or the glucose analog methyl-D-glucopyranoside (MDG) (both nonmetabolizable sweeteners that do not close KATP channels). Fifteen healthy eumenorrheic females were asked to track their urinary estrogen metabolite estrone-3-glucuronide (E3G) via a fertility monitor. The participants were tested using oral detection thresholds for glucose, sucralose and MDG during the E3G nadir at menstruation and E3G peak (>100 ng/mL) at peri-ovulation. Seven male participants were also tested for glucose detection thresholds over the same 2-wk interval. Female participants were also asked to rate their liking for glucose solutions at mildly sweet (450 mM) and moderately sweet (900 mM) concentrations. Detection thresholds for glucose, but not sucralose or MDG, decreased peri-ovulation during estrogen peak (P < 0.05), indicating enhanced sensitivity to glucose specifically. Males showed no change in glucose threshold over the 2 wk. Liking ratings for 900 mM glucose tended to increase during ovulation (P = 0.06). These observations are consistent with the idea that estrogen and/or other co-modulating hormones, such as luteinizing hormone and progesterone, enhance a metabolic signaling pathway during the peri-ovulatory phase.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.